CGEM – cullinan oncology, inc. (US:NASDAQ)
Stock Stats
News
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
Cullinan Therapeutics (NASDAQ:CGEM) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Cullinan Therapeutics (NASDAQ:CGEM) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit
Cullinan Therapeutics (NASDAQ:CGEM) is now covered by analysts at Citigroup Inc.. They set a "buy" rating on the stock.
Form 144 Cullinan Therapeutics, Filed by: Michaelson Jennifer
Form SCHEDULE 13G Cullinan Therapeutics, Filed by: Kynam Capital Management, LP
Form 4 Cullinan Therapeutics, For: Feb 25 Filed by: Michaelson Jennifer
Form 4 Cullinan Therapeutics, For: Feb 24 Filed by: SUMER JACQUELYN L
Form 4 Cullinan Therapeutics, For: Feb 23 Filed by: Michaelson Jennifer
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.